دورية أكاديمية

Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies.

التفاصيل البيبلوغرافية
العنوان: Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies.
المؤلفون: Zenklusen I; Clinical Immunology Unit, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Switzerland., Jongo S; Ifakara Health Institute, Clinical Trial Unit, Bagamoyo, Tanzania., Abdulla S; Ifakara Health Institute, Clinical Trial Unit, Bagamoyo, Tanzania., Ramadhani K; Ifakara Health Institute, Clinical Trial Unit, Bagamoyo, Tanzania., Lee Sim BK; Sanaria Inc., Rockville, Maryland., Cardamone H; Center for Infectious Disease Research, Seattle, Washington., Flannery EL; Center for Infectious Disease Research, Seattle, Washington., Nguyen T; Center for Infectious Disease Research, Seattle, Washington., Fishbaugher M; Center for Infectious Disease Research, Seattle, Washington., Steel RWJ; Center for Infectious Disease Research, Seattle, Washington., Betz W; Center for Infectious Disease Research, Seattle, Washington., Carmago N; Center for Infectious Disease Research, Seattle, Washington., Mikolajczak S; Center for Infectious Disease Research, Seattle, Washington., Kappe SHI; Center for Infectious Disease Research, Seattle, Washington.; Department of Global Health, University of Washington, Seattle., Hoffman SL; Sanaria Inc., Rockville, Maryland., Sack BK; Center for Infectious Disease Research, Seattle, Washington., Daubenberger C; Clinical Immunology Unit, Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Switzerland.
المصدر: The Journal of infectious diseases [J Infect Dis] 2018 Apr 23; Vol. 217 (10), pp. 1569-1578.
نوع المنشور: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
أسماء مطبوعة: Publication: Jan. 2011- : Oxford : Oxford University Press
Original Publication: 1904-2010 : Chicago, IL : University of Chicago Press
مواضيع طبية MeSH: Antibodies, Protozoan/*immunology , Immunoglobulin M/*immunology , Malaria/*immunology , Malaria Vaccines/*immunology , Malaria, Falciparum/*immunology, Adult ; Antibody Formation/immunology ; Double-Blind Method ; Humans ; Immunization/methods ; Male ; Plasmodium falciparum/immunology ; Sporozoites/immunology ; Vaccination/methods ; Vaccines, Attenuated/immunology ; Volunteers ; Young Adult
مستخلص: Background: The assessment of antibody responses after immunization with radiation-attenuated, aseptic, purified, cryopreserved Plasmodium falciparum sporozoites (Sanaria PfSPZ Vaccine) has focused on IgG isotype antibodies. Here, we aimed to investigate if P. falciparum sporozoite binding and invasion-inhibitory IgM antibodies are induced following immunization of malaria-preexposed volunteers with PfSPZ Vaccine.
Methods: Using serum from volunteers immunized with PfSPZ, we measured vaccine-induced IgG and IgM antibodies to P. falciparum circumsporozoite protein (PfCSP) via ELISA. Function of this serum as well as IgM antibody fractions was measured via in vitro in an inhibition of sporozoite invasion assay. These IgM antibody fractions were also measured for binding to sporozoites by immunofluorescence assay and complement fixation on whole sporozoites.
Results: We found that in addition to anti-PfCSP IgG, malaria-preexposed volunteers developed anti-PfCSP IgM antibodies after immunization with PfSPZ Vaccine and that these IgM antibodies inhibited P. falciparum sporozoite invasion of hepatocytes in vitro. These IgM plasma fractions also fixed complement to whole P. falciparum sporozoites.
Conclusions: This is the first finding that PfCSP and P. falciparum sporozoite-binding IgM antibodies are induced following immunization of PfSPZ Vaccine in malaria-preexposed individuals and that IgM antibodies can inhibit P. falciparum sporozoite invasion into hepatocytes in vitro and fix complement on sporozoites. These findings indicate that the immunological assessment of PfSPZ Vaccine-induced antibody responses could be more sensitive if they include parasite-specific IgM in addition to IgG antibodies.
Clinical Trials Registration: NCT02132299.
References: J Immunol Methods. 1989 Dec 20;125(1-2):147-58. (PMID: 2607149)
Sci Transl Med. 2017 Jan 4;9(371):. (PMID: 28053159)
Immunity. 2015 Mar 17;42(3):580-90. (PMID: 25786180)
PLoS One. 2013 Apr 16;8(4):e61395. (PMID: 23613845)
Nat Med. 2016 Jun;22(6):614-23. (PMID: 27158907)
Malar J. 2013 Apr 22;12:136. (PMID: 23607541)
J Infect Dis. 2002 Apr 15;185(8):1155-64. (PMID: 11930326)
Immunity. 2016 Aug 16;45(2):402-14. (PMID: 27473412)
Mol Biochem Parasitol. 2012 May;183(1):100-3. (PMID: 22342965)
Future Microbiol. 2015;10(10):1553-78. (PMID: 26437872)
JCI Insight. 2017 Jan 12;2(1):e89154. (PMID: 28097230)
NPJ Vaccines. 2017 Oct 9;2:27. (PMID: 29263882)
Trans R Soc Trop Med Hyg. 1974;68(3):258-9. (PMID: 4608063)
Malar J. 2014 Apr 05;13:136. (PMID: 24708526)
Nat Commun. 2016 Jun 07;7:11826. (PMID: 27270306)
Vaccine. 2015 Dec 22;33(52):7452-61. (PMID: 26469720)
Mol Cell Proteomics. 2011 Sep;10(9):M111.007948. (PMID: 21628511)
N Engl J Med. 2016 Jun 30;374(26):2519-29. (PMID: 27355532)
N Engl J Med. 1986 Sep 4;315(10):601-6. (PMID: 3526148)
Am J Med Sci. 1973 Dec;266(6):398-403. (PMID: 4590095)
Parasitology. 2016 Feb;143(2):199-207. (PMID: 26743747)
Proc Natl Acad Sci U S A. 2017 Mar 7;114(10 ):2711-2716. (PMID: 28223498)
Science. 2013 Sep 20;341(6152):1359-65. (PMID: 23929949)
Science. 1987 Aug 7;237(4815):639-42. (PMID: 3299709)
Exp Parasitol. 1994 May;78(3):294-301. (PMID: 8162961)
Cell. 2014 Dec 4;159(6):1277-89. (PMID: 25480293)
J Biol Chem. 2009 Sep 25;284(39):26951-63. (PMID: 19633296)
Nature. 2006 Dec 14;444(7121):937-40. (PMID: 17151604)
Lancet Infect Dis. 2017 May;17 (5):498-509. (PMID: 28216244)
Clin Exp Immunol. 2008 Jan;151(1):42-50. (PMID: 18005364)
Science. 1987 Apr 24;236(4800):453-6. (PMID: 3551073)
Wkly Epidemiol Rec. 2016 Jan 4;91(4):33-51. (PMID: 26829826)
Malar J. 2016 May 31;15:301. (PMID: 27245446)
Mol Immunol. 2014 Nov;62(1):104-13. (PMID: 24980869)
Science. 2011 Oct 28;334(6055):475-80. (PMID: 21903775)
Nature. 2017 Feb 23;542(7642):445-449. (PMID: 28199305)
PLoS Pathog. 2015 May 14;11(5):e1004855. (PMID: 25974076)
J Immunol. 2013 Apr 1;190(7):3039-46. (PMID: 23526829)
Immunity. 1997 Jul;7(1):97-112. (PMID: 9252123)
Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):E546-55. (PMID: 25624468)
J Neurosurg. 1981 Jul;55(1):19-26. (PMID: 7017080)
N Engl J Med. 2009 Jul 30;361(5):468-77. (PMID: 19641203)
Cell Rep. 2016 Dec 20;17 (12 ):3193-3205. (PMID: 28009289)
Lancet. 2011 May 21;377(9779):1770-6. (PMID: 21514658)
معلومات مُعتمدة: F32 AI114113 United States AI NIAID NIH HHS; R44 AI055229 United States AI NIAID NIH HHS
سلسلة جزيئية: ClinicalTrials.gov NCT02132299
المشرفين على المادة: 0 (Antibodies, Protozoan)
0 (Immunoglobulin M)
0 (Malaria Vaccines)
0 (Vaccines, Attenuated)
تواريخ الأحداث: Date Created: 20180214 Date Completed: 20190905 Latest Revision: 20190906
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC5913598
DOI: 10.1093/infdis/jiy080
PMID: 29438525
قاعدة البيانات: MEDLINE
الوصف
تدمد:1537-6613
DOI:10.1093/infdis/jiy080